Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report

Autor: Coudert, B, Anthoney, A, Fiedler, W, Droz, J.P, Dieras, V, Borner, M, Smyth, J.F, Morant, R, de Vries, M.J, Roelvink, M, Fumoleau, P
Zdroj: In European Journal of Cancer 2001 37(17):2194-2198
Databáze: ScienceDirect
Externí odkaz: